Last updated date
ABOUT THIS STUDY
This is a first-in-humans study of GSI-136, a drug being developed for the treatment of Alzheimer Disease. The main purpose of this study is to determine whether GSI-136 is safe and tolerable in healthy young and healthy elderly subjects. The amount of drug in the body and the effects of the drug on the body will also be evaluated at certain timepoints.
New York, New York, 10019, United States
Alzheimer Disease, Healthy
Females and Males
18 + years
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
Alzheimer Disease, HealthyStudy GSI-136 in Healthy Young and Healthy Elderly Subjects
- New York, New York
Alzheimer Disease, HealthyStudy Evaluating Safety of GSI 136 in Young and Elderly Japanese Males
Alzheimer Disease, HealthyStudy Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects
- Kitashinagawa, Shinagawa-ku, Tokyo
Alzheimer Disease, HealthyStudy Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953
- 5-4-12, Kitashinagawa, Shinagawa-ku